Literature DB >> 53833

Immunochemical evidence for a common variable region in three immunoglobulin classes in the same individual.

A O Grubb, O H Zettervall.   

Abstract

One IgG1(kappa), one IgM(kappa), and one IgA1(kappa) monoclonal (M)-component were purified from one human serum. Rabbit antisera were raised against the IgG and IgM M-components and were absorbed until specific for idiotypic determinants on these molecules. All three M-components gave reactions of immunological identity when tested by double radial immunodiffusion with either of the two idiotype-specific antisera. Both heavy and light chains were isolated from each of the three M-components and all preparations inhibited formation of idiotypic precipitates. None of these preparations formed precipitates with idiotype-specific antisera alone. When heavy or light chains of one M-component were hybridized with light or heavy chains from the other M-components the resultant molecules precipitated with anti-idiotypic serum. Hybrids with chains from polyclonal IgG were not precipitable with such antiserum. These results indicate that the variable region of the heavy chains of these M-components of three different immunoglobulin classes are closely similar, if not identical.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53833      PMCID: PMC433149          DOI: 10.1073/pnas.72.10.4115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Production of antibodies of identical idiotype but diverse immunoglobulin classes by cells derived from a single stimulated B cell.

Authors:  P J Gearhart; N H Sigal; N R Klinman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

2.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

3.  The molecular basis of antibody formation: a paradox.

Authors:  W J Dreyer; J C Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

4.  Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line.

Authors:  R A Rudders; V Yakulis; P Heller
Journal:  Am J Med       Date:  1973-08       Impact factor: 4.965

5.  Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM.

Authors:  Y Yagi; D Pressman
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

6.  Agarose gel electrophoresis.

Authors:  B G Johansson
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

7.  [Methods of determination of the subclass of heavy chains of human -G immunoglobulins].

Authors:  C Rivat; L Rivat; J Bourguignon; C Ropartz
Journal:  Immunochemistry       Date:  1971-09

8.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

9.  Sharing of individual antigenic determinants between a gamma G and a gamma M protein in the same myeloma serum.

Authors:  G M Penn; H G Kunkel; H M Grey
Journal:  Proc Soc Exp Biol Med       Date:  1970-12

10.  Recombination of heavy and light chains of human gamma-a-myeloma proteins: formation of hybrid molecules and configurational specificity.

Authors:  R A Prendergast; H M Grey; H G Kunkel
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  2 in total

1.  Three monoclonal immunoglobulins, an IgG2(kappa), an IgM(kappa) and an IgM/A hybrid, in one patient. II. Sharing of common variable regions.

Authors:  T K Kuan; E Tung; I Y Wang; A C Wang
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

2.  Human triclonal anti-IgG gammopathy. I. Iso-electric focusing characteristics of the IgG, IgA and IgM anti-IgG and their heavy and light chains.

Authors:  G N Abraham
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.